» Articles » PMID: 25225112

Left Ventricular Dilation and Incident Congestive Heart Failure in Asymptomatic Adults Without Cardiovascular Disease: Multi-ethnic Study of Atherosclerosis (MESA)

Overview
Journal J Card Fail
Date 2014 Sep 17
PMID 25225112
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Limited data exist on the association between left ventricular (LV) dilation/remodeling and incident heart failure (HF), especially in adults without prior myocardial infarction (MI) and valvular heart disease. We assessed the association between LV dilation and remodeling and incident HF in a multiethnic cohort.

Methods And Results: A total of 4,974 of 6,814 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) had cardiac magnetic resonance imaging and complete data. Kaplan-Meier and Cox proportional hazard analyses were used to assess the association between LV end-diastolic diameter (LVEDD) and adjudicated HF. During the 12 years of follow-up (mean 9.4 y), 177 (3.6%) HF events occurred, 126 (71.2%) in HF with reduced ejection fraction (EF) and 51 (28.8%) in HF with preserved EF. LV dilation (LVEDD >52 mm or >95th percentile) was associated with HF in univariate (hazard ratio [HR] 1.21, 95% confidence interval [CI] 1.08-1.46; P = .007) and multivariable Cox models (HR 1.28, 95% CI 1.09-1.57; P = .01) adjusting for traditional risk factors, medication use, LV EF, and interim MI. We found a significant multiplicative interaction between LVEDD and LV EF in our full multivariable models. Participants with dilated LV and preserved EF had increased risk [HR 2.22, 95% CI 1.46-3.37; P = .006) and those with dilated LV and reduced EF had worse prognosis (HR 7.35, 95% CI 2.36-22.85; P = .0006) compared with normal-size LV and preserved EF. A high proportion of participants with LV dilation had eccentric remodeling, a risk factor for HF. Concentric hypertrophy, also a risk factor for HF, was common in the normal-size LV group.

Conclusions: LV dilation predicts incident HF independently from risk factors, LV EF, and interim MI.

Citing Articles

Predicting the risk of heart failure after acute myocardial infarction using an interpretable machine learning model.

Lin Q, Zhao W, Zhang H, Chen W, Lian S, Ruan Q Front Cardiovasc Med. 2025; 12:1444323.

PMID: 39925976 PMC: 11802525. DOI: 10.3389/fcvm.2025.1444323.


Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction.

Rowe S, Paratz E, Fahy L, Janssens K, Spencer L, DAmbrosio P JACC Adv. 2025; 4(1):101444.

PMID: 39759435 PMC: 11699313. DOI: 10.1016/j.jacadv.2024.101444.


Proteomics of left ventricular structure in the Multi-Ethnic Study of Atherosclerosis.

Peterson T, Lima J, Shah S, Bluemke D, Bertoni A, Liu Y ESC Heart Fail. 2024; 12(1):239-249.

PMID: 39263947 PMC: 11769605. DOI: 10.1002/ehf2.15073.


The preferable position for quantifying left ventricular diameter by transthoracic echocardiography.

Nakayama T, Shintani Y, Yokoi M, Goto T, Oishi Y, Ikehara N J Echocardiogr. 2024; 23(1):24-40.

PMID: 39222201 DOI: 10.1007/s12574-024-00658-8.


Pulse wave signal-driven machine learning for identifying left ventricular enlargement in heart failure patients.

Wu D, Ono R, Wang S, Kobayashi Y, Sughimoto K, Liu H Biomed Eng Online. 2024; 23(1):60.

PMID: 38909231 PMC: 11193305. DOI: 10.1186/s12938-024-01257-5.


References
1.
Levy D, Kenchaiah S, Larson M, Benjamin E, Kupka M, Ho K . Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347(18):1397-402. DOI: 10.1056/NEJMoa020265. View

2.
Yusuf S, Pitt B, Davis C, Hood Jr W, Cohn J . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327(10):685-91. DOI: 10.1056/NEJM199209033271003. View

3.
Konstam M, Kramer D, Patel A, Maron M, Udelson J . Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011; 4(1):98-108. DOI: 10.1016/j.jcmg.2010.10.008. View

4.
Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

5.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View